e-learning
resources
Vienna 2012
Monday, 03.09.2012
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: RC kinase: A novel kinase expressed by alveolar macrophages that may play a role in COPD and IPF
S. Boehme, J. Ludka, D. DiTirro, A. L. Coelho, C. Hogaboam, T. W. Ly, K. Bacon (San Diego, Ann Arbor, United States Of America)
Source:
Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session:
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session type:
Thematic Poster Session
Number:
2124
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Boehme, J. Ludka, D. DiTirro, A. L. Coelho, C. Hogaboam, T. W. Ly, K. Bacon (San Diego, Ann Arbor, United States Of America). LATE-BREAKING ABSTRACT: RC kinase: A novel kinase expressed by alveolar macrophages that may play a role in COPD and IPF. Eur Respir J 2012; 40: Suppl. 56, 2124
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
LATE-BREAKING ABSTRACT: Defective macrophage phagocytosis in COPD is associated with reduced STAT1 phosphorylation
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
LATE-BREAKING ABSTRACT: PI3K p110γ is overexpressed in IPF lung tissue and fibroblast cells. In vitro effects of its inhibition
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
The role of NRF-2 and p38 MAPK on the function of human parenchymal fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1426-1433
Year: 2015
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 147s
Year: 2006
Wnt-inducible protein (WISP-1) is a key regulator of alveolar epithelial cell hyperplasia in pulmonary fibrosis
Source: Eur Respir Rev 2006; 15: 180-181
Year: 2006
LATE-BREAKING ABSTRACT: Defect of HDAC7 causes impaired VEGF expression in response to hypoxia in COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
The oncogene c-Src plays a crucial role in the pathogenesis of COPD
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
The effect of a novel phosphoinositide 3-kinase Δ inhibitor (PI3KΔ), GSK2269557, on potential biomarkers measured from the lungs of healthy male smokers
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Alveolar macrophages activate STAT3 in epithelial cells via gp130 dependant steroid insensitive mechanism
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Role of IκB kinases (IKKs) α and β in severe asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 2s
Year: 2005
IPF fibroblasts secrete low levels of KGF: involvement of the JNK pathway
Source: Eur Respir J 2004; 24: Suppl. 48, 481s
Year: 2004
LSC 2010 Abstract: Protease-activated receptor-2 plays a pivotal role in pulmonary fibrosis by inducing myofibroblast differentiation and tissue factor up-regulation
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001
The matrix-fibroblast interplay contributes to HIF-1 alpha pathway activation: a possible therapeutic target in idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept